This is how the T-Mobile President and CEO increased market cap to $165 billion, jumped from 20 to 100 million customers, and increased the company stock price 70%.
The pandemic accelerated the use of digital and virtual technologies in clinical trials particularly around patient interaction and support. What will that mean going forward?